Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach

Objective: To evaluate a new treatment for dysmenorrhea by mechanically inducing menstrual fluid streaming. Setting: A 4-month randomized double-blind, placebo-controlled, crossover study. Participants: Study participants included women experiencing dysmenorrhea monthly (for the 6 preceding months)...

Full description

Bibliographic Details
Main Authors: Hilla Shaviv, Doron J. D. Rosen, Yossef Ezra
Format: Article
Language:English
Published: Taylor & Francis Group 2018-01-01
Series:Cogent Medicine
Subjects:
Online Access:http://dx.doi.org/10.1080/2331205X.2018.1501933
id doaj-59e2a69717344709b401d4a2cafd619c
record_format Article
spelling doaj-59e2a69717344709b401d4a2cafd619c2021-03-18T14:42:11ZengTaylor & Francis GroupCogent Medicine2331-205X2018-01-015110.1080/2331205X.2018.15019331501933Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approachHilla Shaviv0Doron J. D. Rosen1Yossef Ezra2GalMedics Biotech LtdMeir Medical CenterHadassah Hebrew University Medical CenterObjective: To evaluate a new treatment for dysmenorrhea by mechanically inducing menstrual fluid streaming. Setting: A 4-month randomized double-blind, placebo-controlled, crossover study. Participants: Study participants included women experiencing dysmenorrhea monthly (for the 6 preceding months) at a level >5 on the visual analog scale (0–10), who were otherwise healthy. The study participants also collected their menstrual fluid for 2 baseline months, while recording their pain levels (primary outcome) systematically. A correlation between menstrual fluid characteristics and menstrual pain was studied as well. Intervention: A newly invented device was used to attenuate dysmenorrheic pain level. Results: From September 2011 to December 2013, 28 study participants were enrolled; three withdrew and three were excluded for protocol non-adherence. Twenty-two study participants (132 menstrual cycles) who used the device reported an average reduction of 55 ± 7.6% in pain levels vs. 22 ± 12% reported with placebo (p = 0.008). In addition, analysis of menstrual fluid collected from 19 study participants (38 menstrual cycles) showed that high pain levels necessarily involve tissue fragments or a viscous menstrual fluid, supporting the idea that dysmenorrhea is associated with the rheological characteristics of the menstrual fluid. Conclusions: The new device is highly effective in relieving menstrual pain. Rheological characteristics of the menses are correlated with severity of dysmenorrhea.http://dx.doi.org/10.1080/2331205X.2018.1501933dysmenorrheamensesrandomized trialrheologyvaginal deviceactilady
collection DOAJ
language English
format Article
sources DOAJ
author Hilla Shaviv
Doron J. D. Rosen
Yossef Ezra
spellingShingle Hilla Shaviv
Doron J. D. Rosen
Yossef Ezra
Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach
Cogent Medicine
dysmenorrhea
menses
randomized trial
rheology
vaginal device
actilady
author_facet Hilla Shaviv
Doron J. D. Rosen
Yossef Ezra
author_sort Hilla Shaviv
title Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach
title_short Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach
title_full Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach
title_fullStr Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach
title_full_unstemmed Dysmenorrhea: A randomized controlled clinical trial evaluating a novel treatment approach
title_sort dysmenorrhea: a randomized controlled clinical trial evaluating a novel treatment approach
publisher Taylor & Francis Group
series Cogent Medicine
issn 2331-205X
publishDate 2018-01-01
description Objective: To evaluate a new treatment for dysmenorrhea by mechanically inducing menstrual fluid streaming. Setting: A 4-month randomized double-blind, placebo-controlled, crossover study. Participants: Study participants included women experiencing dysmenorrhea monthly (for the 6 preceding months) at a level >5 on the visual analog scale (0–10), who were otherwise healthy. The study participants also collected their menstrual fluid for 2 baseline months, while recording their pain levels (primary outcome) systematically. A correlation between menstrual fluid characteristics and menstrual pain was studied as well. Intervention: A newly invented device was used to attenuate dysmenorrheic pain level. Results: From September 2011 to December 2013, 28 study participants were enrolled; three withdrew and three were excluded for protocol non-adherence. Twenty-two study participants (132 menstrual cycles) who used the device reported an average reduction of 55 ± 7.6% in pain levels vs. 22 ± 12% reported with placebo (p = 0.008). In addition, analysis of menstrual fluid collected from 19 study participants (38 menstrual cycles) showed that high pain levels necessarily involve tissue fragments or a viscous menstrual fluid, supporting the idea that dysmenorrhea is associated with the rheological characteristics of the menstrual fluid. Conclusions: The new device is highly effective in relieving menstrual pain. Rheological characteristics of the menses are correlated with severity of dysmenorrhea.
topic dysmenorrhea
menses
randomized trial
rheology
vaginal device
actilady
url http://dx.doi.org/10.1080/2331205X.2018.1501933
work_keys_str_mv AT hillashaviv dysmenorrheaarandomizedcontrolledclinicaltrialevaluatinganoveltreatmentapproach
AT doronjdrosen dysmenorrheaarandomizedcontrolledclinicaltrialevaluatinganoveltreatmentapproach
AT yossefezra dysmenorrheaarandomizedcontrolledclinicaltrialevaluatinganoveltreatmentapproach
_version_ 1724215774545969152